Current Neurology and Neuroscience Reports

Papers
(The TQCC of Current Neurology and Neuroscience Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Magnetoencephalography for Epilepsy Presurgical Evaluation147
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas131
Cognitive and Neuropsychiatric Impairment in Dystonia96
The Kinetics of Transtentorial Brain Herniation: Kernohan-Woltman Notch Phenomenon Revisited84
Headache and Autonomic Dysfunction: a Review76
Cognitive Interventions for Neurodegenerative Disease69
Neurological Complications Associated with Hereditary Bleeding Disorders49
Treatment of Pediatric Low-Grade Gliomas46
The Set up and the Triggers: An Update on the Risk Factors for Giant Cell Arteritis42
Sleep Disturbances in Autoimmune Neurological Diseases35
Autonomic Manifestations of Long-COVID Syndrome34
The Impact of Aging on Multiple Sclerosis31
Patient-Centered Management of Brain Tumor-Related Epilepsy28
A New Surgical Option For Patients with Unresolved Bell’s Palsy26
Migraine Management in Medically Complex Patients: a Narrative Review25
Neuro-Visual and Vestibular Manifestations of Concussion and Mild TBI25
Sleep Consequences of Prader-Willi Syndrome25
Sleep and Perivascular Spaces25
Posterior Reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma25
Maculopapillary Bundle Degeneration in Optic Neuropathies24
Neurological Manifestations of Scrub Typhus24
Effects of the Menstrual Cycle on Neurological Disorders24
Central Nervous System Infections in Immunocompromised Patients23
Emerging Therapies for Brain Metastases in NSCLC, Breast Cancer, and Melanoma: A Critical Review23
Correction to: Neurologic Complications of Poverty: the Associations between Poverty as a Social Determinant of Health and Adverse Neurologic Outcomes23
The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature22
Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature22
Subcortical Aphasia22
The More, the Better: High-Dose Omega-3 Fatty Acids Improve Behavioural and Molecular Outcomes in Preclinical Models in Mild Brain Injury22
Retinal Migraine: Evaluation and Management21
Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2—Peripheral Nervous System21
Neuromodulation Treatments for Mild Traumatic Brain Injury and Post-concussive Symptoms21
Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences21
MOG Antibody Disease: Nuances in Presentation, Diagnosis, and Management20
Supporting Post-Stroke Language and Cognition with Pharmacotherapy: Tools for Each Phase of Care20
The association between dynamic balance and executive function: Which dynamic balance test has the strongest association with executive function? A systematic review and meta-analysis20
Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography20
Novel Therapies for Primary Central Nervous System Lymphomas19
Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease19
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia19
Neurocritical Care Recovery Clinics: An Idea Whose Time Has Come18
Brain Cancers in Genetic Syndromes17
Apraxia: From Neuroanatomical Pathways to Clinical Manifestations17
Neurologic Complications of Cancer Therapies17
Modern Sedation and Analgesia Strategies in Neurocritical Care17
Internal Carotid Artery Occlusion: Management17
Recent Advances in the Impact of Infection and Inflammation on Stroke Risk and Outcomes17
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection16
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop16
Pre-diabetes, Diabetes, Hyperglycemia, and Stroke: Bittersweet Therapeutic Opportunities16
Thalamic Aphasia: a Review16
Headache in COVID-19 and Long COVID: to Know Facts for Clinical Practice15
Traumatic Brain Injury and Gut Microbiome: The Role of the Gut-Brain Axis in Neurodegenerative Processes15
Granulomatous Diseases of the Central Nervous System15
Update on Strategies to Reduce Early Brain Injury after Subarachnoid Hemorrhage15
Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis15
Huntington’s Disease: Latest Frontiers in Therapeutics15
Utilizing Implementation Science to Bridge Cerebrovascular Health Disparities: a Local to Global Perspective15
Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies15
The Glymphatic System and its Relationship to Migraine14
Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities14
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review14
Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data14
De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis14
Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders13
Sleep Duration and Executive Function in Adults13
Surgical Treatment of Drug-Resistant Generalized Epilepsy13
Neurological Manifestations of Histiocytic Disorders13
Updates in the Management of Giant Cell Arteritis13
Cerebrovascular Complications Associated with Marijuana Use13
Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas13
The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease13
Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis13
Palliative Care in Neuro-oncology: an Update13
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis13
Neuroplasticity in Diffuse Low-grade Gliomas: Backward Modelling of Brain-tumor Interactions Prior to Diagnosis is Needed to Better Predict Recovery after Treatment13
0.081705093383789